首頁 > 市場調查報告書 > 製藥

肥胖症

市場調查報告書

商品編碼

1935155

鹽酸芬特明市場：按類型、應用、藥物類型、產品類型、年齡層、通路、地區分類

Phentermine Hydrochloride Market, By Type, By Application, By Drug Type, By Product Type, By Age Group, By Distribution Channel, By Geography

出版日期: 2026年01月07日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，鹽酸芬特明市值將達到 6.098 億美元，到 2033 年將達到 9.921 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 7.2%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	6.098億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	7.20%	2033 年的預測值：	9.921億美元

全球鹽酸芬特明市場是製藥業的重要組成部分，其主要產品是目前應用最廣泛的用於肥胖症治療的食慾抑制劑之一。鹽酸芬特明是一種擬交感神經胺類藥物，它透過刺激中樞神經系統來抑制食慾，從而達到抑制食慾、促進減重的效果，尤其適用於配合飲食和運動計畫。該市場涵蓋多種劑型，包括速釋片、緩釋膠囊和口溶錠，幫助全球醫療專業人員和患者應對日益嚴重的肥胖問題。

全球肥胖率不斷攀升，人們對體重相關健康併發症日益關注，以及對有效藥物干預措施在體重管理方面的需求不斷成長，都進一步凸顯了該市場的重要性。主要市場參與企業包括製藥公司、學名藥企業、醫療服務提供者和監管機構，他們透過產品開發、臨床研究、監管核准和分銷策略共同塑造市場動態。該市場在高度監管的環境下運作，需要嚴格的安全通訊協定和療效驗證，同時也要滿足不同地區、醫療基礎設施和肥胖盛行率各異的多元化患者群體的需求。

市場動態

全球鹽酸芬特明市場的主要驅動力是日益嚴重的全球肥胖危機。全球超過6.5億成年人被歸類為肥胖，使得對有效體重管理藥物的需求龐大。久坐不動的生活方式、飲食習慣的改變以及遺傳因素都加劇了肥胖率的上升，迫使醫療保健系統尋求鹽酸芬特明等藥物解決方案。

醫療專業人員和患者對肥胖相關健康風險（例如糖尿病、心血管疾病和代謝紊亂）的認知不斷提高，進一步推動了市場成長。此外，新興國家醫療基礎設施的擴張、醫療支出的增加以及醫療保險覆蓋範圍的擴大，也有助於改善市場准入。

然而，市場有許多限制，包括對管制物質的嚴格法規結構、潛在的副作用（如心血管併發症）、依賴風險以及對某些疾病患者的禁忌症。

建議療程通常僅為12週或更短，這限制了其長期市場潛力；此外，來自其他體重管理療法和外科手術的競爭也帶來了進一步的挑戰。然而，透過持續研發聯合治療、緩釋製劑和新型給藥機制，可望提高療效和安全性，從而蘊藏著巨大的發展機會。

個人化醫療方法的開發、將數位健康平台整合到綜合體重管理方案中以及向尚未開發的市場拓展，都蘊藏著盈利的成長機會。此外，對預防性醫療保健的日益重視、醫療旅遊的興起以及延長治療療程獲得監管部門核准的可能性，都可能顯著擴大市場機遇，同時更有效地應對全球肥胖問題。

本次調查的主要特點

本報告對全球鹽酸芬特明市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）內的市場規模和復合年成長率（%）。
我們也將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
該研究根據以下參數對全球鹽酸芬特明市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份全球鹽酸芬特明市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種策略矩陣輕鬆做出決策，這些矩陣用於分析全球鹽酸芬特明市場。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Chemische Fabrik Berg GmbH
Malladi Drugs &Pharmaceuticals Limited
Moehs Iberica
Tenatra Exports
Biotechnica DWC
Siegfried AG
Cambrex Corporation
Cody Laboratories, Inc.
Fagron Group
Gyma Laboratories of America
Letco Medical
Medisca
Olon SpA
Sun Pharmaceutical Industries Limited
Symed Labs

第12章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9186

Phentermine Hydrochloride Market is estimated to be valued at USD 609.8 Mn in 2026 and is expected to reach USD 992.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 609.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.20%	2033 Value Projection:	USD 992.1 Mn

The global phentermine hydrochloride market represents a critical segment within the pharmaceutical industry, focusing on one of the most widely prescribed appetite suppressant medications for obesity management. Phentermine hydrochloride, a sympathomimetic amine, functions as an anorectic agent that stimulates the central nervous system to reduce appetite and promote weight loss in conjunction with diet and exercise programs. This market encompasses various formulations including immediate-release tablets, extended-release capsules, and orally disintegrating tablets, serving healthcare providers and patients worldwide in addressing the growing obesity epidemic.

The market's significance has intensified due to rising obesity rates globally, increasing awareness about weight-related health complications, and the growing demand for effective pharmacological interventions for weight management. Key market participants include pharmaceutical manufacturers, generic drug producers, healthcare providers, and regulatory bodies that collectively shape market dynamics through product development, clinical research, regulatory approvals, and distribution strategies. The market operates within a highly regulated environment, requiring stringent safety protocols and efficacy demonstrations, while addressing diverse patient populations across different geographical regions with varying healthcare infrastructures and obesity prevalence rates.

Market Dynamics

The global phentermine hydrochloride market is primarily driven by the escalating global obesity crisis, with over 650 Mn adults classified as obese worldwide, creating substantial demand for effective weight management pharmaceuticals. Increasing sedentary lifestyles, dietary changes, and genetic predispositions contribute to rising obesity rates, compelling healthcare systems to seek pharmacological solutions like phentermine hydrochloride.

Growing awareness among healthcare professionals and patients about the health risks associated with obesity, including diabetes, cardiovascular diseases, and metabolic disorders, further propels market growth. Additionally, expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, and growing medical insurance coverage enhance market accessibility.

However, the market faces significant restraints including stringent regulatory frameworks governing controlled substances, potential side effects such as cardiovascular complications, dependency risks, and contraindications for patients with certain medical conditions.

Limited treatment duration recommendations, typically 12 weeks or less, restrict long-term market potential, while competition from alternative weight management therapies and surgical interventions poses additional challenges. Nevertheless, substantial opportunities exist through ongoing research and development for combination therapies, extended-release formulations, and novel delivery mechanisms that could improve efficacy and safety profiles.

The development of personalized medicine approaches, integration of digital health platforms for comprehensive weight management programs, and expansion into underserved markets present lucrative growth avenues. Furthermore, increasing focus on preventive healthcare, rising medical tourism, and potential regulatory approvals for extended treatment durations could significantly expand market opportunities while addressing the global obesity burden more effectively.

Key Features of the Study

This report provides in-depth analysis of the global phentermine hydrochloride market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global phentermine hydrochloride market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Chemische Fabrik Berg GmbH, Malladi Drugs & Pharmaceuticals Limited, Moehs Iberica, Tenatra Exports, Biotechnica DWC, Siegfried AG, Cambrex Corporation, Cody Laboratories, Inc., Fagron Group, Gyma Laboratories of America, Letco Medical, Medisca, Olon S.p.A, Sun Pharmaceutical Industries Limited, and Symed Labs.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global phentermine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phentermine hydrochloride market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
- Immediate-Release (IR) Tablets
- Extended-Release (ER) Tablets
- Capsules
- Oral Solution
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Obesity Treatment
- Weight Loss Management
- Appetite Suppressant
- Adjunct Therapy for Obesity-Related Conditions
Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Prescription Drugs
- Over-the-Counter (OTC) Drugs
Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Brand
- Generic
Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Adult
- Pediatric
- Geriatric
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Chemische Fabrik Berg GmbH
- Malladi Drugs & Pharmaceuticals Limited
- Moehs Iberica
- Tenatra Exports
- Biotechnica DWC
- Siegfried AG
- Cambrex Corporation
- Cody Laboratories, Inc.
- Fagron Group
- Gyma Laboratories of America
- Letco Medical
- Medisca
- Olon S.p.A
- Sun Pharmaceutical Industries Limited
- Symed Labs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Phentermine Hydrochloride Market, By Type
- Global Phentermine Hydrochloride Market, By Application
- Global Phentermine Hydrochloride Market, By Drug Type
- Global Phentermine Hydrochloride Market, By Product Type
- Global Phentermine Hydrochloride Market, By Age Group
- Global Phentermine Hydrochloride Market, By Distribution Channel
- Global Phentermine Hydrochloride Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Phentermine Hydrochloride Market, By Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Immediate-Release (IR) Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Extended-Release (ER) Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Oral Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Phentermine Hydrochloride Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Obesity Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Weight Loss Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Appetite Suppressant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Adjunct Therapy for Obesity-Related Conditions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Phentermine Hydrochloride Market, By Drug Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Over-the-Counter (OTC) Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Phentermine Hydrochloride Market, By Product Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Brand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Phentermine Hydrochloride Market, By Age Group, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Phentermine Hydrochloride Market, By Distribution Channel, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global Phentermine Hydrochloride Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Chemische Fabrik Berg GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Malladi Drugs & Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moehs Iberica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Tenatra Exports
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotechnica DWC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siegfried AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cambrex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cody Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fagron Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gyma Laboratories of America
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Letco Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medisca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Olon S.p.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Symed Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies